找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Management of Prostate Cancer; Eric A. Klein,J. Stephen Jones Book 2013Latest edition Springer Science+Business Media, LLC 2013 Brachyther

[复制链接]
查看: 47984|回复: 63
发表于 2025-3-21 18:05:52 | 显示全部楼层 |阅读模式
书目名称Management of Prostate Cancer
编辑Eric A. Klein,J. Stephen Jones
视频video
概述Focuses on the full spectrum of disease from current molecular and genetic hypotheses regarding risk and progression.Authors will represent a broad spectrum of opinion and expertise in the prostate ca
丛书名称Current Clinical Urology
图书封面Titlebook: Management of Prostate Cancer;  Eric A. Klein,J. Stephen Jones Book 2013Latest edition Springer Science+Business Media, LLC 2013 Brachyther
描述.The thoroughly updated and revised third edition of .Management of Prostate Cancer .provides concise and authoritative guidance to today‘s best therapeutic regimens for the diagnosis and treatment of prostate cancer.  Highlighting the latest major advances in the field, the book. .includes chapters on the most controversial areas of prostate cancer – screening, chemoprevention, and active surveillance; updated chapters on genetic risk and progression, biopsy schemes, treatment of complications, and comparative treatment outcomes for surgery; and new chapters on risk factors, new markers, nomograms, and focal therapy. This volume also features overviews of new and emerging drugs and treatment paradigms for castrate resistant disease, advances that promise to extend life and perhaps even cure a subset of men with metastatic disease..With its comprehensive illustrations and contributions from renowned experts in the field, .Management of Prostate Cancer, 3.rd. Edition .is an invaluable resource for practitioners in the treatment of prostate cancer. .
出版日期Book 2013Latest edition
关键词Brachytherapy; Cancer Screening; PSA; Prostate; Prostate Biopsy; Prostatectomy; Radiation therapy
版次3
doihttps://doi.org/10.1007/978-1-60761-259-9
isbn_softcover978-1-61779-739-2
isbn_ebook978-1-60761-259-9Series ISSN 2197-7194 Series E-ISSN 2197-7208
issn_series 2197-7194
copyrightSpringer Science+Business Media, LLC 2013
The information of publication is updating

书目名称Management of Prostate Cancer影响因子(影响力)




书目名称Management of Prostate Cancer影响因子(影响力)学科排名




书目名称Management of Prostate Cancer网络公开度




书目名称Management of Prostate Cancer网络公开度学科排名




书目名称Management of Prostate Cancer被引频次




书目名称Management of Prostate Cancer被引频次学科排名




书目名称Management of Prostate Cancer年度引用




书目名称Management of Prostate Cancer年度引用学科排名




书目名称Management of Prostate Cancer读者反馈




书目名称Management of Prostate Cancer读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:32:58 | 显示全部楼层
发表于 2025-3-22 01:39:46 | 显示全部楼层
Beyond PSA: Promising New Markers for Prostate Cancer, TMPRSS2:ERG are of keen interest. At the tissue level the methylation marker GST-P1 and the proliferation index Ki-67 appear potentially valuable..Future biomarkers will help improve CaP specificity and also predict lethality of CaP vis-a-vis current limitations of serum PSA.
发表于 2025-3-22 06:46:03 | 显示全部楼层
Current Issues in Pathologic Evaluation,ter, the practical aspects of pathological assessing and reporting of prostate cancer in different surgical specimens are addressed, with a special emphasis on areas of current consensus on Gleason grading and staging.
发表于 2025-3-22 10:43:02 | 显示全部楼层
发表于 2025-3-22 15:10:59 | 显示全部楼层
发表于 2025-3-22 17:52:35 | 显示全部楼层
发表于 2025-3-22 21:31:24 | 显示全部楼层
The Utility of Nomograms in Routine Clinical Practice, of use, and their ability to generate outcomes tailored to the individual patient. In this chapter, we discuss the integral role of outcomes prediction in prostate cancer and how nomograms can facilitate decision-making at various clinical states of disease.
发表于 2025-3-23 02:06:46 | 显示全部楼层
Active Surveillance Comes of Age,lence. In fact, mortality of all of these cancers has remained stable or declined. The stable or falling mortality rates for these cancers suggests that overdiagnosis is accounting for a significant proportion of the additional cases.
发表于 2025-3-23 09:25:11 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-15 04:09
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表